GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PT Merck Tbk (ISX:MERK) » Definitions » Book Value per Share

PT Merck Tbk (ISX:MERK) Book Value per Share : Rp1,831.40 (As of Mar. 2025)


View and export this data going back to 1981. Start your Free Trial

What is PT Merck Tbk Book Value per Share?

PT Merck Tbk's book value per share for the quarter that ended in Mar. 2025 was Rp1,831.40.

During the past 12 months, PT Merck Tbk's average Book Value Per Share Growth Rate was 0.10% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 5.70% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 7.20% per year. During the past 10 years, the average Book Value Per Share Growth Rate was 4.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the book value growth rate using book value per share data.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of PT Merck Tbk was 22.00% per year. The lowest was -0.10% per year. And the median was 5.70% per year.

PT Merck Tbk's current price is Rp3610.00. Its book value per share for the quarter that ended in Mar. 2025 was Rp1,831.40. Hence, today's PB Ratio of PT Merck Tbk is 1.97.

During the past 13 years, the highest P/B Ratio of PT Merck Tbk was 9.11. The lowest was 1.01. And the median was 2.89.


PT Merck Tbk Book Value per Share Historical Data

The historical data trend for PT Merck Tbk's Book Value per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PT Merck Tbk Book Value per Share Chart

PT Merck Tbk Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Book Value per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,367.60 1,526.88 1,690.27 1,776.52 1,801.95

PT Merck Tbk Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Book Value per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,829.32 1,561.87 1,628.52 1,801.95 1,831.40

Competitive Comparison of PT Merck Tbk's Book Value per Share

For the Drug Manufacturers - Specialty & Generic subindustry, PT Merck Tbk's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PT Merck Tbk's PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, PT Merck Tbk's PB Ratio distribution charts can be found below:

* The bar in red indicates where PT Merck Tbk's PB Ratio falls into.


;
;

PT Merck Tbk Book Value per Share Calculation

PT Merck Tbk's Book Value Per Share for the fiscal year that ended in Dec. 2024 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(807,274-0)/448
=1,801.95

PT Merck Tbk's Book Value Per Share for the quarter that ended in Mar. 2025 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(820,467-0)/448
=1,831.40

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Theoretically it is what the shareholders will receive if the company is liquidated. Total Stockholders Equity is a balance sheet item and equal to Total Assets less Total Liabilities of the company.

Book value may include intangible items which may come from the company's past acquisitions. Book value less intangibles is called Tangible Book.


PT Merck Tbk  (ISX:MERK) Book Value per Share Explanation

Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.

For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.


PT Merck Tbk Book Value per Share Related Terms

Thank you for viewing the detailed overview of PT Merck Tbk's Book Value per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


PT Merck Tbk Business Description

Traded in Other Exchanges
N/A
Address
Jalan T.B. Simatupang No. 8, Pasar Rebo, Jakarta Timur, IDN, 13760
PT Merck Tbk engages in the manufacture and sale of pharmaceutical products in Indonesia. The company operates in three segments: Biopharma, Consumer Health, and Others. The company offers pharmaceutical and biological prescription medicines for colorectal cancer, head and neck tumors, multiple sclerosis, infertility, growth hormone disorders, cardiovascular disorders, diabetes, as well as thyroid disorders such as hypothyroidism.

PT Merck Tbk Headlines

No Headlines